Executive Board

Emile Lens - Chief Executive Officer

Emile Lens

Chief Executive Officer

Over the last five years, Emile has been dedicated to driving and executing buy and build strategies in the life sciences industry. His primary focus at Synexa is to build a company that is considered a top class place for scientists to work, delivering the highest quality services to its clients, and to create a sustainable platform that is scalable, efficient, rapidly growing and that will have a meaningful impact on the world.

Emile holds a MSc degree in Economics at Erasmus University. He started his career in banking at MeesPierson. He subsequently moved to ABN AMRO NV, where he ultimately became Head of Mergers and Acquisitions and part of the global M&A and Capital Market management team. He served as CFO and board member at Maxeda DIY, a leading European retail company owned by KKR. As an entrepreneur, he founded Albacore Partners (an M&A boutique) and Nobilo Ventures (an investment boutique). Prior to joining Synexa, Emile served as CFO and board member of Avania, a global medical device CRO, where he was deeply involved in the successful buy and build strategy of that company.

Emile is passionate about working with people, building businesses, and being part of the innovation and the opportunities that are created by the life sciences industry.

Dr. Justin Devine - Chief Innovation Officer

Dr. Justin Devine

Chief Innovation Officer

Justin is a medical doctor, immunologist and pharmacologist (Stellenbosch University) and a co-founder of Synexa.

His primary focus is to understand our clients’ objectives in new drug development by designing biomarker strategies to bring real insight to the challenges of clinical development. Justin has a very deep understanding of the role that biomarkers and pharmacogenetics play in understanding the performance of a candidate drug.

He is particularly passionate about improving the drug development process by bringing innovative approaches to early phase research, including new ideas in translational medicine, bioinformatics and artificial intelligence

Nadia Borchards - Chief Finance Officer

Nadia Borchards

Chief Finance Officer

Nadia holds a Post Graduate Diploma in Business Administration (PGDBA) from the University of the Western Cape, Cape Town. With an undergrad degree in Biomedical Technology, her career started in the diagnostic pathology sphere in 2001. Since 2015, Nadia’s role has transitioned from diagnostic pathology operations to finance and procurement.

She is passionate about seeing Synexa and its people thrive and flourish. Her focus is to create and sustain the necessary support infrastructure for a fast-growing company to succeed.